Capital Investment Advisory Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Capital Investment Advisory Services’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$501K	Buy	4,231 +10	+0.2%	+$1.08K	0.03%	441
2026 Q1	$438K	Sell	4,221 -40	-0.9%	-$4.22K	0.03%	426
2025 Q4	$445K	Buy	4,261 +10	+0.2%	+$1.01K	0.03%	406
2025 Q3	$393K	Sell	4,251 -165	-4%	-$14.4K	0.03%	420
2025 Q2	$353K	Buy	4,416 +15	+0.3%	+$1.2K	0.03%	415
2025 Q1	$381K	Sell	4,401 -11	-0.2%	-$937	0.03%	371
2024 Q4	$365K	Buy	4,412 +10	+0.2%	+$860	0.04%	358
2024 Q3	$383K	Buy	4,402 +10	+0.2%	+$856	0.04%	347
2024 Q2	$361K	Sell	4,392 -925	-17%	-$73.5K	0.04%	354
2024 Q1	$426K	Buy	5,317 +9	+0.2%	+$697	0.05%	333
2023 Q4	$404K	Sell	5,308 -1,763	-25%	-$126K	0.04%	342
2023 Q3	$512K	Sell	7,071 -430	-6%	-$33K	0.05%	273
2023 Q2	$567K	Buy	7,501 +15	+0.2%	+$1.15K	0.06%	255
2023 Q1	$569K	Buy	7,486 +19	+0.3%	+$1.47K	0.07%	241
2022 Q4	$587K	Buy	7,467 +7,038	+1,641%	+$541K	0.07%	237
2022 Q3	$31K	Buy	429 +1	+0.2%	+$75	﹤0.01%	611
2022 Q2	$32K	Hold	428	–	–	﹤0.01%	634
2022 Q1	$34K	Sell	428 -49	-10%	-$3.8K	﹤0.01%	663
2021 Q4	$39K	Buy	477 +1	+0.2%	+$79	﹤0.01%	627
2021 Q3	$37K	Hold	476	–	–	﹤0.01%	587
2021 Q2	$38K	Sell	476 -51	-10%	-$4.05K	﹤0.01%	606
2021 Q1	$42K	Sell	527 -150	-22%	-$11.7K	0.01%	555
2020 Q4	$48K	Buy	677 +1	+0.1%	+$67	0.01%	524
2020 Q3	$43K	Hold	676	–	–	0.01%	459
2020 Q2	$44K	Buy	676 +526	+351%	+$32.7K	0.01%	414
2020 Q1	$8K	Buy	150 +50	+50%	+$3.04K	﹤0.01%	483
2019 Q4	$6K	Hold	100	–	–	﹤0.01%	500
2019 Q3	$6K	Hold	100	–	–	﹤0.01%	1099
2019 Q2	$6K	Hold	100	–	–	﹤0.01%	1100
2019 Q1	$7K	Hold	100	–	–	﹤0.01%	906
2018 Q4	$6K	Buy	+100	New	+$6.75K	﹤0.01%	908

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Capital Investment Advisory Services's PJP Position: Q2 2026 in Review

Capital Investment Advisory Services increased its Invesco Pharmaceuticals ETF (PJP) stake by 0.24% in Q2 2026, buying an estimated $1.08K and bringing the position to 4,231 shares worth $501K. The position accounts for 0.03% of the portfolio, ranked #441.

Capital Investment Advisory Services first reported a position in PJP in Q4 2018 and has held it in 31 quarters since. The position peaked at $587K in Q4 2022. 92 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Capital Investment Advisory Services held 4,231 shares of Invesco Pharmaceuticals ETF worth $501K as of Q2 2026.
Capital Investment Advisory Services bought 10 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $1.08K.
Invesco Pharmaceuticals ETF made up 0.03% of Capital Investment Advisory Services's portfolio in Q2 2026, its #441 holding.
Capital Investment Advisory Services first reported a position in Invesco Pharmaceuticals ETF in Q4 2018 and has held it in 31 quarters since.
Capital Investment Advisory Services's Invesco Pharmaceuticals ETF position peaked at $587K in Q4 2022.
92 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.